Tim-3 was first discovered on Th1 cells and exhibited functions as a co-inhibitory receptor that down-regulates the activity of tumor infiltrating lymphocytes (TIL) in different types of cancer [11–13]. The gene discussed is HAVCR2; the disease is neoplasm.